Recruiting

Observational Study

Sponsor:

Georgetown University

Code:

NCT02275091

Conditions

Diabetes Mellitus, Type 1

Diabetes Complications

Eligibility Criteria

Sex: All

Age: 12 - 21

Healthy Volunteers: Accepted

Study Details

Brief summary:

Patients with type 1 diabetes type 1 (DM1) have increased risk of death due to heart disease and stroke. These cardiovascular conditions (CVD) are the leading cause of death in patients with DM1 younger than 40 years of age and up to 35% of all persons with DM1 will die before age 55 from CVD. Strategies are needed to help identify adolescents with DM1 at risk for CVD so that interventions to prevent heart disease and stroke can be undertaken.

Conditions

Diabetes Mellitus, Type 1

Diabetes Complications

Study ID

NCT02275091

Start date

Oct, 2014

Status verified date

Apr, 2019

Completion date

Oct, 2020

Anticipated

Primary completion date

Oct, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12 - 21

Healthy Volunteers: Accepted

Inclusion Criteria:

Diabetes type 1 or Healthy

Exclusion Criteria:

Taking medications that lower cholesterol Duration of type 1 diabetes < 1 year.

Study Design

Enrollment

240 participants

Anticipated

Interventions and Outcome Measures

Arms

Diabetes

Children with diabetes type 1 , 12-21 years old

Healthy

Healthy children 12-21 years old

Primary outcome measure

  • small LDL particles [ Time Frame: This is an observational cross sectional study. Samples will be collected through study completion, on average of 6 years duration. ]

Central Contacts and Locations

Central contacts

Evgenia Gourgari, MD

2024441210

Kathryn Turner

2024442639

Locations

Georgetown-Howard Universities Center

Recruiting

Washington, District of Columbia, United States, 20007

Contacts

Stephanie Gubb

202-444-1210

Principal Investigator:

Evgenia Gourgari, MD

More Information

Sponsor

Georgetown University

Last update posted

Apr 5, 2019

Last verified

Apr, 2019

Keywords

  • Children
  • Cholesterol

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Georgetown University on 2019-04-05.